GE Healthcare is working with the University of Oxford-led National Consortium of Intelligent Medical Imaging (NCIMI) to develop and test algorithms to aid in the diagnosis and management of Covid-19 pneumonia.
The programme will focus on predicting, enhancing and testing potential algorithms to diagnose Covid-19 pneumonia and predict which patients will develop severe respiratory distress, and which patients might develop long-term lung function problems even after they recover.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Identification of the highest-risk patients could help physicians to accelerate intensive care support, while lower-risk patients could be discharged from hospital sooner.
GE Healthcare president and CEO Kieran Murphy said: “As health systems manage Covid-19 cases, clinicians can benefit from new technologies to help triage and determine which patients are likely to develop respiratory distress and longer-term complications. If we can ensure patients are quickly placed in the right care setting, this may help to improve outcomes.”
